Dr. Manisha Singh is an eminent Gynaecologist and a sub-specialist in Reproductive Medicine & Surgery with over 32 years of extensive surgical experience. She is also an acknowledged expert in Reproductive Medicine and Surgery services by Royal College of Obstetricians and Gynaecologists (RCOG), London, UK. Dr. Manisha Singh has an experience of over 32 years in Obstetrics, Gynaecology, Infertility & Assisted Conception treatments.
The outcome of a Frozen Embryo Replacement Cycle can depend on several clinical and biological factors. These factors are assessed by the fertility specialist while planning the treatment and preparing the uterus for embryo transfer.
Age, particularly at the time the embryo was created, is an important factor that may influence treatment outcomes. Egg quality generally declines with increasing age, which can affect embryo development and implantation potential.
The quality of the embryo is an important consideration in a frozen embryo transfer. Embryos that develop appropriately and survive the freezing and thawing process may have better implantation potential.
The stage at which the embryo was frozen, such as the cleavage stage or blastocyst stage, may influence its implantation potential and is considered while planning the transfer.
The uterine lining needs to be appropriately prepared for embryo implantation. The fertility team monitors the thickness and appearance of the endometrium and coordinates the timing of embryo transfer accordingly.
The overall health of the uterus can influence implantation. Conditions such as uterine polyps, fibroids, adhesions, or other abnormalities may need to be evaluated and managed before embryo transfer when clinically necessary.
Oestrogen and progesterone play an important role in preparing and maintaining the uterine lining. Hormone levels and treatment response may therefore be monitored during a hormone-prepared Frozen Embryo Replacement Cycle.
Certain medical or fertility-related conditions, including endometriosis, thyroid disorders, and other reproductive health concerns, may influence treatment outcomes. Appropriate assessment and management may be recommended before or during treatment.
The quality of the sperm and egg at the time of fertilisation can influence embryo development and overall embryo quality. These factors may therefore contribute to the implantation potential of an embryo used during a frozen embryo transfer.
Dr Manisha Rajpal Singh provides fertility care with an individualised approach to Frozen Embryo Replacement Cycle treatment. Treatment planning may include assessment of the patient’s fertility history, menstrual and ovulation pattern, uterine lining, previous treatment cycles, and reproductive goals.
Her approach includes personalised fertility treatment planning and individualised endometrial preparation based on the patient’s clinical requirements. Dr Singh evaluates the available embryos, uterine condition, and appropriate transfer protocol before developing a treatment plan suited to each patient.
Book an Appointment
Schedule a consultation with Dr Manisha Rajpal Singh to discuss personalised frozen embryo transfer treatment and the most appropriate approach based on your fertility needs.
A Frozen Embryo Replacement Cycle (FERC) is a planned fertility treatment cycle in which a previously cryopreserved embryo is thawed and transferred into the uterus.
Yes. Frozen Embryo Replacement Cycle (FERC) and Frozen Embryo Transfer (FET) are commonly used to describe the process of transferring a previously frozen embryo into the uterus during a planned treatment cycle.
A FERC may be considered for patients who have frozen embryos from a previous IVF cycle and are planning an embryo transfer. It may also be used after a freeze-all IVF cycle or following preimplantation genetic testing, depending on the treatment plan.
A blood pregnancy test is usually performed around 10 to 14 days after the embryo transfer, depending on the treatment protocol and the fertility specialist’s recommendation.